Cargando…

The association between wearable activity monitor metrics and performance status in oncology: a systematic review

PURPOSE: The expanding armamentarium of wearable activity monitors (WAMs) offers new opportunities to supplement physician-assessed performance status (PS) with real-life patient activity data. These data could guide clinical decision making or serve as a measure of treatment outcome. However, infor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kos, Milan, Pijnappel, Esther N., Buffart, Laurien M., Balvers, Britt R., Kampshoff, Caroline S., Wilmink, Johanna W., van Laarhoven, Hanneke W. M., van Oijen, Martijn G. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464563/ https://www.ncbi.nlm.nih.gov/pubmed/34117567 http://dx.doi.org/10.1007/s00520-021-06234-5

Ejemplares similares

Ecological momentary assessments among patients with cancer: A scoping review
por: Kampshoff, Caroline S., et al.
Publicado: (2019)

The Use of (Network) Meta-Analysis in Clinical Oncology
por: ter Veer, Emil, et al.
Publicado: (2019)

Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis
por: Augustinus, Simone, et al.
Publicado: (2023)

Design of the Resistance and Endurance exercise After ChemoTherapy (REACT) study: A randomized controlled trial to evaluate the effectiveness and cost-effectiveness of exercise interventions after chemotherapy on physical fitness and fatigue
por: Kampshoff, Caroline S, et al.
Publicado: (2010)

Determinants of exercise adherence and maintenance among cancer survivors: a systematic review
por: Kampshoff, Caroline S, et al.
Publicado: (2014)

Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study
por: Kampshoff, Caroline S., et al.
Publicado: (2015)

Demographic, clinical, psychosocial, and environmental correlates of objectively assessed physical activity among breast cancer survivors
por: Kampshoff, Caroline S, et al.
Publicado: (2016)

Participation in and adherence to physical exercise after completion of primary cancer treatment
por: Kampshoff, Caroline S., et al.
Publicado: (2016)

Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
por: Pijnappel, Esther N., et al.
Publicado: (2021)

Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors
por: Kampshoff, C. S., et al.
Publicado: (2018)

The fear of cancer recurrence and progression in patients with pancreatic cancer
por: Pijnappel, Esther N., et al.
Publicado: (2022)

From presentation to paper: Gender disparities in oncological research
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: van Mackelenbergh, Madelaine G., et al.
Publicado: (2019)

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
por: ter Veer, Emil, et al.
Publicado: (2016)

Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review
por: ter Veer, Emil, et al.
Publicado: (2018)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Spiritual care by nurses in curative oncology: a mixed‐method study on patients’ perspectives and experiences
por: Ebenau, Anne, et al.
Publicado: (2019)

IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
por: Khurshed, Mohammed, et al.
Publicado: (2018)

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature
por: ter Veer, Emil, et al.
Publicado: (2016)

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
por: ter Veer, Emil, et al.
Publicado: (2017)

Comparison of six fit algorithms for the intra-voxel incoherent motion model of diffusion-weighted magnetic resonance imaging data of pancreatic cancer patients
por: Gurney-Champion, Oliver J., et al.
Publicado: (2018)

Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
por: Douma, Joeri A. J., et al.
Publicado: (2020)

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
por: Douma, Joeri A. J., et al.
Publicado: (2021)

P1411: FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS
por: Kos, Milan, et al.
Publicado: (2023)

Health-Care Metrics in Oncology
por: Gilbert, Elizabeth, et al.
Publicado: (2015)

Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
por: van der Geest, Lydia G. M., et al.
Publicado: (2017)

Using Hexoskin Wearable Technology to Obtain Body Metrics During Trail Hiking
por: MONTES, JEFF, et al.
Publicado: (2015)

Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study
por: Latenstein, Anouk E. J., et al.
Publicado: (2020)

COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer
por: Douma, Joeri A. J., et al.
Publicado: (2018)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

SPOTlight on GLOW
por: Derks, Sarah, et al.
Publicado: (2023)

Continuous Monitoring of Vital Signs Using Wearable Devices on the General Ward: Pilot Study
por: Weenk, Mariska, et al.
Publicado: (2017)

Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel
por: Steins, Anne, et al.
Publicado: (2017)

Physical activity in patients with cancer: self-report versus accelerometer assessments
por: Douma, Joeri A.J., et al.
Publicado: (2019)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Correction: Continuous Monitoring of Vital Signs Using Wearable Devices on the General Ward: Pilot Study
por: Weenk, Mariska, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_appe3cqamrc0jkaqpqil16baok